Novartis Services, Inc.
Registered Principal Details
Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Vas Narasimhan
US Country Head of Government Affairs
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Vas Narasimhan
US Country Head of Government Affairs
Contact
DC
Daniel Casserly
801 Pennsylvania Ave. N.W., Suite 700
Washington, DC 20004
(202) 662-4361
(202) 628-4764
dan.casserly@novartis.com
http://www.novartis.com
801 Pennsylvania Ave. N.W., Suite 700
Washington, DC 20004
(202) 662-4361
(202) 628-4764
dan.casserly@novartis.com
http://www.novartis.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Dee George | Exclusive Duties N/A | Authorized On 12/21/2016 | Withdrawn On N/A |
| George Klaetsch | Exclusive Duties N/A | Authorized On 4/14/2017 | Withdrawn On 10/3/2018 |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
12/4/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
For
Notification Date12/4/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
For
Notification Date11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Biosimilars
Biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
8/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
8/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $7,000.00 |
2017 July - December $15,800.82 |
2018 January - June $11,263.22 |
2018 July - December $7,500.00 |
Total $41,564.05 |
| Total Hours Communicating | 2017 January - June 0.50 |
2017 July - December 16.00 |
2018 January - June 8.25 |
2018 July - December 2.00 |
Total 26.75 |
| Total Hours Other | 2017 January - June 4.50 |
2017 July - December 28.50 |
2018 January - June 28.00 |
2018 July - December 9.00 |
Total 70.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 22% |
2018 January - June 10% |
2018 July - December |
Total 14% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 38% |
2018 January - June 75% |
2018 July - December |
Total 45% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 20% |
2018 January - June |
2018 July - December |
Total 9% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication